BOCA RATON, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will moderate a panel discussion on cross-border biopharma collaboration during the Longwood Healthcare Leaders San Francisco CEO Conference taking place January 6-7, 2024, prior to the 42nd Annual JP Morgan Healthcare Conference.
The panel, titled, "Cross-Border Collaboration," will include Ed Hu, Vice Chair & Global CIO, WuXi; Richard Paulson, CEO, Karyopharm; and Nikolay Savchuk, Managing Partner, TealTech.
Details of the panel discussion are as follows:
Event: | Longwood Healthcare Leaders San Francisco CEO Conference |